TRADD as a Regulator of Cytokine Signaling in Glia
TRADD 作为神经胶质细胞因子信号传导的调节剂
基本信息
- 批准号:7455118
- 负责人:
- 金额:$ 28.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-19 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAcuteAdaptor Signaling ProteinAddressAffectAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisApoptosisAstrocytesBindingBiologicalBrainCell NucleusCell Surface ReceptorsCell physiologyCell surfaceCellsChronicCognitiveCommunicationComplexCytokine SignalingDNA BindingDataDeath DomainDefense MechanismsDimerizationDiseaseElementsEmotionalEndothelial CellsEpidermal Growth FactorEventFamily memberGene ExpressionGenesGenetic TranscriptionGoalsGranulocyte-Macrophage Colony-Stimulating FactorHumanImmuneImmune responseInflammationInflammatoryInflammatory ResponseInjuryInterferonsInterleukin-10Interleukin-12Interleukin-13Interleukin-4Interleukin-6IschemiaLeadLocalizedMacrophage ActivationMediatingMicrogliaMolecularMultiple SclerosisNatureNeuraxisNeurogliaNeuronsNuclearNuclear ProteinNuclear ProteinsNuclear TranslocationNumbersPTPN11 genePathologyPathway interactionsPersonal SatisfactionPhosphoric Monoester HydrolasesPhosphorylationPhysiologicalPlayProcessProductionProtein DephosphorylationProtein OverexpressionProtein Tyrosine PhosphataseProteinsReceptor ActivationRecruitment ActivityRegulationResearchResearch PersonnelRoleSTAT proteinSeriesSerineSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSiteSourceStimulusSynaptic plasticityTestingTumor Necrosis Factor ReceptorTyrosineTyrosine PhosphorylationVirus Diseasesbasecell growthcell typechemokineconceptcytokineinterestmacrophageneurogenesisneuroinflammationneuropathologyneurotoxicitynoveloncostatin Mparacrineprogramspromoterprotein protein interactionreceptorreconstitutionresearch studyresponserestorationscaffoldtranscription factor
项目摘要
DESCRIPTION (provided by applicant): Inflammatory events in the Central Nervous System (CNS) contribute to the pathology underlying diseases such as Multiple Sclerosis (MS), Alzheimer's Disease (AD) and HIV-1 Associated Dementia (HAD), and activated macrophages/microglia are central to this response. Immunological activation of these cells leads to the production of cytokines that ultimately impact on glial and neuronal function. Macrophages/microglia also respond to cytokines upon engagement of cell surface receptors and activation of complex intracellular signaling pathways. Dysregulation of macrophage/microglial cytokine production and responsiveness is a critical determinant of the neuroimmunologic cascades that typify diseases such as MS, AD and HAD. IFN- and TNF-a are potent activators of macrophages and microglia, and are aberrantly expressed in the CNS in the diseases mentioned above. IFN-y uses Signal Transducer and Activator of Transcription-la (STAT-la) for signal transduction, while the Tumor Necrosis Factor Receptor 1 (TNFRl)-associated death domain (TRADD) protein is critical for TNF-a signaling. We have discovered a novel and unanticipated form of crosstalk between the IFN? and TNF-a signaling pathways that is operational in macrophages/microglia. Specifically, we have demonstrated that IFN-? induces the formation of a nuclear-localized TRADD-STAT-la complex. In this configuration, we propose that TRADD is involved in the dephosphorylation of STAT-la since IFN-?-induced STAT-la phosphorylation, DNA binding activity, nuclear retention and transcriptional activity are enhanced in cells with reduced TRADD levels. We hypothesize that TRADD has a functional role in regulating the response of macrophages/microglia to IFN-?, impacting on cellular activation and subsequent neuroinflammatory responses. The function of TRADD on IFN-?-induced gene expression in macrophages/microglia will be studied, focusing on genes critical for immunological responses (Aim 1). Two strategies are proposed: depletion of TRADD as well as TRADD reconstitution and/or overexpression. In Aim 2, we will test the hypothesis that TRADD is involved in the STAT-la dephosphorylation process, perhaps by interacting with STAT-la phosphatases to regulate their localization and/or activity. A critical issue is how signaling from the IFN-? receptor induces nuclear localization of TRADD, and subsequent TRADD-STAT-la complex formation. The experiments in Aim 3 will address these questions. Lastly, we will examine the ability of other cytokines that use the STAT pathway to induce TRADD-STAT complex formation, and the repertoire of cell types in which TRADD-STAT interactions occur (Aim 4). Our studies will provide a comprehensive assessment of TRADD function in cytokine signaling, thereby advancing our understanding of this novel signaling pathway in the context of macrophage/microglial activation and neuroinflammation.
描述(由申请人提供):中枢神经系统中的炎症事件(CNS)有助于诸如多发性硬化症(MS),阿尔茨海默氏病(AD)和HIV-1相关痴呆症(HAS)以及激活的巨噬细胞/小胶质细胞等病理的核心。这些细胞的免疫学激活导致产生最终影响神经胶质和神经元功能的细胞因子。巨噬细胞/小胶质细胞还会在细胞表面受体接合并激活复杂细胞内信号通路后对细胞因子反应。巨噬细胞/小胶质细胞因子的产生和反应性的失调是典型的MS,AD和HAT等疾病的神经免疫性级联反应的关键决定因素。 IFN和TNF-A是巨噬细胞和小胶质细胞的有效活化剂,并且在上述疾病中的中枢神经系统中异常表达。 IFN-Y使用转录-LA(Stat-LA)的信号传感器和激活因子进行信号转导,而肿瘤坏死因子受体1(TNFRL)相关的死亡结构域(TRADD)蛋白对于TNF-A信号传导至关重要。我们在IFN之间发现了一种新颖而意外的串扰形式?在巨噬细胞/小胶质细胞中运行的TNF-A信号通路。具体来说,我们已经证明了IFN-?诱导核定位的Tradd-STAT-LA复合体的形成。在这种配置中,我们建议传统参与Stat-LA的去磷酸化,因为IFN - ? - 诱导的STAT-LA磷酸化,DNA结合活性,核保留和转录活性在降低的Tradd水平的细胞中增强了。我们假设TRADD在调节巨噬细胞/小胶质细胞对IFN-的反应中具有功能性作用,从而影响细胞激活和随后的神经炎症反应。将研究传统对巨噬细胞/小胶质细胞中诱导基因表达的功能,重点是对免疫反应至关重要的基因(AIM 1)。提出了两种策略:Tradd的耗尽以及Tradd重建和/或过表达。在AIM 2中,我们将通过与Stat-La磷酸酶相互作用以调节其定位和/或活动的相互作用来检验TRADD参与Stat-LA去磷酸化过程的假设。一个关键的问题是如何发出IFN-的信号?受体诱导传统的核定位,并随后的传统-STAT-LA复合体形成。 AIM 3中的实验将解决这些问题。最后,我们将研究使用统计途径诱导传统stat复合形成的其他细胞因子的能力,以及发生传统相互作用的细胞类型的曲目(AIM 4)。我们的研究将对细胞因子信号传导中传统功能进行全面评估,从而在巨噬细胞/小胶质细胞激活和神经炎症的背景下促进我们对这一新型信号通路的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Etty N Benveniste其他文献
Etty N Benveniste的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Etty N Benveniste', 18)}}的其他基金
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD
项目 2:验证 JAK/STAT 通路作为 PD 的新型治疗策略
- 批准号:
9976624 - 财政年份:2018
- 资助金额:
$ 28.71万 - 项目类别:
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD
项目 2:验证 JAK/STAT 通路作为 PD 的新型治疗策略
- 批准号:
10469388 - 财政年份:2018
- 资助金额:
$ 28.71万 - 项目类别:
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
靶向胶质瘤中的 JAK/STAT-3 通路信号轴
- 批准号:
8434816 - 财政年份:2012
- 资助金额:
$ 28.71万 - 项目类别:
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
靶向胶质瘤中的 JAK/STAT-3 通路信号轴
- 批准号:
8237478 - 财政年份:2012
- 资助金额:
$ 28.71万 - 项目类别:
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
靶向胶质瘤中的 JAK/STAT-3 通路信号轴
- 批准号:
8618781 - 财政年份:2012
- 资助金额:
$ 28.71万 - 项目类别:
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation
JAK/STAT 通路对神经炎症的治疗干预
- 批准号:
8630636 - 财政年份:2007
- 资助金额:
$ 28.71万 - 项目类别:
Expression and Function of SOCS Proteins in Glial Cells
SOCS 蛋白在胶质细胞中的表达和功能
- 批准号:
7313365 - 财政年份:2007
- 资助金额:
$ 28.71万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
TRADD as a Regulator of Cytokine Signaling in Glia
TRADD 作为神经胶质细胞因子信号传导的调节剂
- 批准号:
7625096 - 财政年份:2005
- 资助金额:
$ 28.71万 - 项目类别:
TRADD as a Regulator of Cytokine Signaling in Glia
TRADD 作为神经胶质细胞因子信号传导的调节剂
- 批准号:
7243364 - 财政年份:2005
- 资助金额:
$ 28.71万 - 项目类别:
TRADD as a Regulator of Cytokine Signaling in Glia
TRADD 作为神经胶质细胞因子信号传导的调节剂
- 批准号:
7912166 - 财政年份:2005
- 资助金额:
$ 28.71万 - 项目类别: